Test Validated to Predict Recurrence Risk and Radiation Therapy Benefit in Breast Cancer
A blinded validation in more than 400 women shows the test provides clearer guidance on recurrence risk and radiation therapy decisions.
A blinded validation in more than 400 women shows the test provides clearer guidance on recurrence risk and radiation therapy decisions.
A longitudinal study finds blood-based biomarkers more sensitive than PET scans in detecting obesity's impact on Alzheimer's pathology.
UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.
The Mercy Halo test demonstrates performance similar to low-dose CT screening with the potential to reach underscreened populations.
The Liaison Plex Gastrointestinal Flex Assay detects 24 targets and offers broad parasite coverage with pay-per-target flexibility.
The molecular diagnostic system can identify complicated UTI pathogens and antibiotic resistance markers at the point-of-care in approximately 15 minutes.
The gene expression test is designed to identify patients more likely to respond to JAK inhibitors versus Th2-targeted therapies.
The test measures two sugar alcohols to detect SORD-related neuropathy, which standard genetic tests sometimes miss.
The collaboration aims to make home-based Alzheimer's biomarker testing more accessible through virtually painless blood collection technology.
The automated system uses ion exchange HPLC technology to deliver A1c results while detecting common hemoglobin variants.
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
The rapid diagnostic test achieved 100% sensitivity and negative predictive value in a 107-patient evaluation at Bordeaux University Hospital.